We are live on ! Find out more
KCM

Knoll Capital Management Portfolio holdings

AUM $180M
1-Year Est. Return 66.11%
This Fund
S&P 500
This Quarter Est. Return
+14.76%
1 Year Est. Return
+66.11%
3 Year Est. Return
+268.55%
5 Year Est. Return
+741%
10 Year Est. Return
+10,877.35%
AUM
$121M
AUM Growth
+$24.4M
Cap. Flow
+$9.05M
Cap. Flow %
7.49%
Top 10 Hldgs %
74.17%
Holding
41
New
4
Increased
9
Reduced
1
Closed
9

Top Buys

Rank Stock Value
1
ALDX icon
Aldeyra Therapeutics
ALDX
+$7.54M
2
SIL icon
Global X Silver Miners ETF NEW
SIL
+$2.22M
3
ENTX icon
Entera Bio
ENTX
+$953K
4
PM icon
Philip Morris
PM
+$921K
5
ITA icon
iShares US Aerospace & Defense ETF
ITA
+$883K

Top Sells

Rank Stock Value
1
FNV icon
Franco-Nevada
FNV
+$1.94M
2
AG icon
First Majestic Silver
AG
+$1.41M
3
MO icon
Altria Group
MO
+$955K
4
LMT icon
Lockheed Martin
LMT
+$879K
5
PAAS icon
Pan American Silver
PAAS
+$783K

Sector Composition

Rank Sector Weight
1 Healthcare 69.45%
2 Materials 17.23%
3 Industrials 2.22%
4 Financials 1.04%
5 Consumer Staples 0.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BHVN
1
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$21M 17.38%
490,422
– –
ALDX icon
2
Aldeyra Therapeutics
ALDX
$91.7M
$19.2M 15.92%
5,475,516
+2,443,601
+81% +$7.54M
APLT
3
DELISTED
Applied Therapeutics
APLT
$18.3M 15.19%
5,474,687
+312,599
+6% +$778K
AVDL
4
DELISTED
Avadel Pharmaceuticals
AVDL
$8.47M 7.02%
600,000
– –
SIL icon
5
Global X Silver Miners ETF NEW
SIL
$4.08B
$4.99M 4.13%
176,000
+86,300
+96% +$2.22M
HOOK
6
DELISTED
HOOKIPA Pharma
HOOK
$4.47M 3.7%
551,739
– –
VRNA
7
DELISTED
Verona Pharma
VRNA
$3.98M 3.29%
200,000
– –
SILV
8
DELISTED
SilverCrest Metals Inc. Common Shares
SILV
$3.08M 2.55%
470,000
+60,000
+15% +$334K
AEM icon
9
Agnico Eagle Mines
AEM
$72.6B
$3.04M 2.52%
55,500
+15,500
+39% +$775K
SA
10
Seabridge Gold
SA
$2.8B
$2.99M 2.48%
246,597
– –
WPM icon
11
Wheaton Precious Metals
WPM
$50.6B
$2.96M 2.45%
60,000
+12,500
+26% +$566K
GDX icon
12
VanEck Gold Miners ETF
GDX
$23B
$2.85M 2.36%
91,850
– –
KGC icon
13
Kinross Gold
KGC
$28.5B
$2.66M 2.2%
440,000
– –
ENTX icon
14
Entera Bio
ENTX
$101M
$2.33M 1.93%
3,881,879
+1,397,604
+56% +$953K
ALT icon
15
Altimmune
ALT
$539M
$2.25M 1.86%
+200,000
New +$835K
EQX icon
16
Equinox Gold
EQX
$7.32B
$2.06M 1.7%
420,929
– –
GDXJ icon
17
VanEck Junior Gold Miners ETF
GDXJ
$7.06B
$2.01M 1.67%
53,150
– –
BAH icon
18
Booz Allen Hamilton
BAH
$8.7B
$1.66M 1.38%
13,000
– –
V icon
19
Visa
V
$677B
$1.25M 1.04%
4,850
– –
CVS icon
20
CVS Health
CVS
$137B
$1.14M 0.95%
14,500
– –
TMO icon
21
Thermo Fisher Scientific
TMO
$211B
$1.11M 0.92%
2,100
– –
MAG
22
DELISTED
MAG Silver
MAG
$1.09M 0.91%
105,000
-55,000
-34% -$588K
AGI icon
23
Alamos Gold
AGI
$12.4B
$1.08M 0.89%
80,000
– –
NOC icon
24
Northrop Grumman
NOC
$77B
$1.01M 0.84%
2,165
– –
PM icon
25
Philip Morris
PM
$301B
$1.01M 0.84%
+10,000
New +$921K
1
2

Similar funds

MGWA
Monument Group Wealth Advisors Concord, Massachusetts $180M AUM 19.81% 1-Year Est. Return
AW
Alchemi Wealth Essex, Connecticut $180M AUM
FBC
Fairfield, Bush & Co Darien, Connecticut $180M AUM 39.51% 1-Year Est. Return
AIC
Aurora Investment Counsel Atlanta, Georgia $180M AUM 0.3% 1-Year Est. Return
AG
Amiral Gestion Paris, France $180M AUM 9.43% 1-Year Est. Return
PCA
Prospect Capital Advisors Sausalito, California $180M AUM 60.99% 1-Year Est. Return
HIC
Hamrick Investment Counsel Seattle, Washington $180M AUM
FFA
Frazier Financial Advisors Columbus, Ohio $181M AUM 11.16% 1-Year Est. Return

Knoll Capital Management's Q4 2023 Portfolio in Review

As of Q4 2023, Knoll Capital Management held 41 positions worth $121M, up 25% from $96.3M the previous quarter. Its ten largest holdings account for 74% of the portfolio.

Knoll Capital Management deployed $9.05M of net new capital in Q4 2023, opening 4 new positions and adding to 9 existing holdings. Its largest new stake was Philip Morris: 10,000 shares worth $1.01M.

By sector, the portfolio is most concentrated in Healthcare at 69% of assets, up from 66% a quarter earlier, followed by Materials and Industrials.

On the sell side, the largest reduction was MAG Silver, an estimated $588K trimmed.

  • Knoll Capital Management's largest Q4 2023 buy was Philip Morris: 10,000 shares worth $1.01M.
  • Knoll Capital Management added most to Aldeyra Therapeutics in Q4 2023, an estimated $7.54M increase.
  • Knoll Capital Management's biggest Q4 2023 reduction was MAG Silver, cutting an estimated $588K.
  • Knoll Capital Management fully exited Franco-Nevada in Q4 2023, selling an estimated $1.94M.
  • Knoll Capital Management's ten largest holdings make up 74% of its $121M portfolio in Q4 2023.
  • Knoll Capital Management opened 4 new positions and closed 9 in Q4 2023.
  • Knoll Capital Management's portfolio value rose 25% quarter-over-quarter to $121M.

Based on Knoll Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.